Etanercept reduces hyperalgesia in experimental painful neuropathy

Journal of the Peripheral Nervous System

Volumn 6, Issue 2, 2001, Pages 67-72

  Sommer, Claudia ^a,b   Schäfers, Maria ^a   Marziniak, Martin ^a   Toyka, Klaus V ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Chronic constriction injury; Etanercept; Neuropathic pain; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; ETANERCEPT; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HYPERALGESIA; INFLAMMATION; MOUSE; NERVE INJURY; NEUROPATHY; NONHUMAN; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCIATIC NERVE;

ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL RESPONSE MODIFIERS; FEMALE; HEAT; HYPERALGESIA; IMMUNOGLOBULIN G; MICE; MICE, INBRED C57BL; PAIN THRESHOLD; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT PROTEINS; SCIATIC NERVE; SCIATIC NEUROPATHY;

EID: 0034952170     PISSN: 10859489     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8027.2001.01010.x     Document Type: Article

References (27)

1. Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans
2. Brain-derived TNFalpha: Involvement in neuroplastic changes implicated in the conscious perception of persistent pain
3. Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy
4. Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model
5. The up-and-down method for small samples
6. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin
7. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury
8. Upregulation of the tumor necrosis factor receptor 1 and 2 in mouse sciatic nerve after chronic constrictive injury
9. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
10. Brain-derived TNFalpha mediates neuropathic pain
11. A systematic review of antidepressants in neuropathic pain
12. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists
13. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein
14. Induction of interleukin-6 in axotomized sensory neurons
15. Hyperalgesia actions of cytokines on the peripheral nervous system
16. Signals for proinflammatory cytokine secretion by human Schwann cells
17. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action
18. A metalloprotease-inhibitor reduces pain associated behavior in mice with experimental neuropathy
19. The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve
20. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1
21. Anti-TNF neutralizing antibodies reduce pain-related behavior in two models of painful mononeuropathy
22. Neutralizing antibodies to inteleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy
23. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat
24. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres
25. Anti-inflammatory interleukin-10 therapy in CCl neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression
26. Endoneurial injection of TNF-alpha produces neuropathic pain behaviors
27. Ethical guidelines for investigations of experimental pain in conscious animals